CAMBRIDGE ENDOSCOPIC DEVICES INC

Profile

Company Names

CAMBRIDGE ENDOSCOPIC DEVICES INC

Addresses

119 HERBERT ST, FRAMINGHAM, MA 01702

Phone Numbers

508-405-0790

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2004

State Incorporated:

DELAWARE

Total Amount Raised:

$5,218,169.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2012-07-26 
$2,924,169.00 
$2,924,169.00 
$0.00 
Debt 
3
2010-04-30 
$60,000.00 
$72,000.00 
$12,000.00 
 
2
2010-01-22 
$734,000.00 
$1,000,000.00 
$266,000.00 
Debt 
1
2009-07-01 
$1,500,000.00 
$1,500,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
OMAR 
 
AMIRANA 
DIRECTOR
CARDIOFOCUS, INC.   |  SMART PILL CORP   |  NFOCUS NEUROMEDICAL, INC.   |  CAMBRIDGE ENDOSCOPIC DEVICES INC
JEFF 
 
BARNES 
DIRECTOR
AQUAGENESIS INC.   |  CLEAN POWER FINANCE, INC.   |  HYDRONOVATION, INC.   |  CAMBRIDGE ENDOSCOPIC DEVICES INC   |  SONOMOTION INC.   |  T-REXECOM, INC.   |  ANGELS + HEROES VENTURE GROWTH FUND 1 LLC
HOWARD 
 
DONNELLY 
DIRECTOR
CAMBRIDGE ENDOSCOPIC DEVICES INC   |  HYDROCISION INC
PHIL 
 
HENDERSON 
DIRECTOR, EXECUTIVE OFFICER
CAMBRIDGE ENDOSCOPIC DEVICES INC
GLEN 
 
KASHUBA 
DIRECTOR
PALYON MEDICAL CORP   |  VENITI, INC.   |  CAMBRIDGE ENDOSCOPIC DEVICES INC   |  CERAPEDICS INC
WOOJIN 
 
LEE 
EXECUTIVE OFFICER, DIRECTOR
CAMBRIDGE ENDOSCOPIC DEVICES INC
JAMES 
 
LOUSARARIAN 
DIRECTOR
VERAX BIOMEDICAL INC   |  CAMBRIDGE ENDOSCOPIC DEVICES INC   |  BIOVENTURES INVESTORS MEDTECH GROWTH CAPITAL, LP   |  UNIFIED INFORMATION DEVICES, INC.   |  TRIOPSY MEDICAL, INC.
JOHN 
 
SCHULTE 
EXECUTIVE OFFICER, DIRECTOR
CARDIOFOCUS, INC.   |  CAMBRIDGE ENDOSCOPIC DEVICES INC   |  REMEDY LABS, INC.
WALTER 
 
WINSHALL 
DIRECTOR
CAMBRIDGE ENDOSCOPIC DEVICES INC   |  SLEEP HEALTHCENTERS LLC   |  PATIENTSLIKEME INC   |  OVULINE, INC.   |  STOCK SNIPS, INC.   |  LIFTWAVE, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2014-01-06
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-07-26 
2012-08-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2010-04-30 
2010-10-08
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-30 
2010-05-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-30 
2010-02-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-01-22 
2009-07-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2009-07-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#